Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

An Age Stratified Analysis of the Access to Care Continuum Across Three Tumor Groups: Are There Delays for AYA?

Pettit T, Sue L, Waugh V, Ballantine K, Gardner K, Bremer L, Pemberton L, Allison L, Adams S, Chou E, Spearing R.

J Adolesc Young Adult Oncol. 2019 Mar 26. doi: 10.1089/jayao.2018.0126. [Epub ahead of print]

PMID:
30912693
2.

Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.

Fukushima T, Ogura K, Akiyama T, Takeshita K, Kawai A.

BMC Musculoskelet Disord. 2018 Aug 18;19(1):297. doi: 10.1186/s12891-018-2217-1.

3.

Who Treats Adolescents and Young Adults with Cancer? A Report from the AYA HOPE Study.

Parsons HM, Harlan LC, Schmidt S, Keegan TH, Lynch CF, Kent EE, Wu XC, Schwartz SM, Chu RL, Keel G, Smith AW; AYA HOPE Collaborative Group.

J Adolesc Young Adult Oncol. 2015 Sep;4(3):141-50. doi: 10.1089/jayao.2014.0041.

4.

Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report.

Fernández KS, Schwartz CL, Chen L, Constine LS, Chauvenet A, de Alarcón PA.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26681. Epub 2017 Jun 14.

5.

Lymphoma in adolescents and young adults.

Jaglowski SM, Linden E, Termuhlen AM, Flynn JM.

Semin Oncol. 2009 Oct;36(5):381-418. doi: 10.1053/j.seminoncol.2009.07.009. Review.

PMID:
19835736
6.

Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.

Kasper B, Ouali M, van Glabbeke M, Blay JY, Bramwell VH, Woll PJ, Hohenberger P, Schöffski P.

Eur J Cancer. 2013 Jan;49(2):449-56. doi: 10.1016/j.ejca.2012.08.007. Epub 2012 Sep 10.

PMID:
22975215
7.

Length of stay and treatment-related complications are similar in pediatric and AYA patients with bone sarcoma in United States children's hospitals.

Audino AN, Yeager ND, Asti L, Miao Y, O'Brien SH.

Pediatr Blood Cancer. 2013 Mar;60(3):415-9. doi: 10.1002/pbc.24231. Epub 2012 Jun 15.

PMID:
22706952
8.

Clinical characteristics and outcomes of diffuse large B-cell lymphoma in adolescents and young adults.

Suzuki Y, Yano T, Suehiro Y, Iwasaki H, Hidaka M, Otsuka M, Sunami K, Inoue N, Sawamura M, Ito T, Iida H, Nagai H.

Int J Hematol. 2018 Aug;108(2):161-166. doi: 10.1007/s12185-018-2449-8. Epub 2018 Mar 31.

PMID:
29605873
9.

A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center.

Sengar M, Akhade A, Nair R, Menon H, Shet T, Gujral S, Sridhar E, Laskar S, Muckaden M.

Indian J Med Paediatr Oncol. 2011 Oct;32(4):197-203. doi: 10.4103/0971-5851.95140.

10.

Current considerations in AYA Hodgkin lymphoma.

Crombie JL, LaCasce AS.

Br J Haematol. 2019 Jan;184(1):72-81. doi: 10.1111/bjh.15640. Epub 2018 Nov 20. Review.

PMID:
30460695
11.

Adolescent and young adult Hodgkin lymphoma: Raising the bar through collaborative science and multidisciplinary care.

Kahn JM, Kelly KM.

Pediatr Blood Cancer. 2018 Jul;65(7):e27033. doi: 10.1002/pbc.27033. Epub 2018 Mar 30. Review.

PMID:
29603618
12.

Cancer in adolescents and young adults in countries with limited resources.

Magrath I, Epelman S.

Curr Oncol Rep. 2013 Aug;15(4):332-46. doi: 10.1007/s11912-013-0327-3. Review.

PMID:
23832788
13.

[Which approach of therapeutic education (TE) for adolescents and young adults with cancer? Experience from the TE working group of "Go-AJA"].

Corradini N, Dagorne L, Retailleau M, Rédini F, Sudour-Bonnange H, Gofti-Laroche L, Le Rhun A, Gaspar N.

Bull Cancer. 2016 Dec;103(12):966-978. doi: 10.1016/j.bulcan.2016.10.006. Epub 2016 Nov 15. French.

PMID:
27863724
14.

Malignant lymphoma in adolescents and young adults: from the viewpoint of physicians.

Maruyama D.

Rinsho Ketsueki. 2017;58(8):1060-1068. doi: 10.11406/rinketsu.58.1060. Japanese.

PMID:
28883270
15.

The Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT) Cohort Study: a population-based cohort of young Canadians with cancer.

Baxter NN, Daly C, Gupta S, Pole JD, Sutradhar R, Greenberg ML, Nathan PC.

BMC Cancer. 2014 Nov 3;14:805. doi: 10.1186/1471-2407-14-805.

16.

Collaboration and Networking.

Husson O, Manten-Horst E, van der Graaf WT.

Prog Tumor Res. 2016;43:50-63. doi: 10.1159/000447071. Epub 2016 Sep 5. Review.

PMID:
27595356
17.

Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.

Kahn JM, Keegan TH, Tao L, Abrahão R, Bleyer A, Viny AD.

Cancer. 2016 Sep 1;122(17):2723-30. doi: 10.1002/cncr.30089. Epub 2016 Jun 10.

18.

Lymphoma in Adolescents and Young Adults.

Brugières L, Brice P.

Prog Tumor Res. 2016;43:101-14. doi: 10.1159/000447080. Epub 2016 Sep 5. Review.

PMID:
27595360
19.

Age at Primary Malignancy Determines Survival in Adolescent and Young Adults That Develop a Secondary Thyroid Cancer.

Lau BJ, Goldfarb M.

J Adolesc Young Adult Oncol. 2016 Jun;5(2):201-8. doi: 10.1089/jayao.2015.0052. Epub 2016 Apr 4.

PMID:
27042962
20.

Prevalence and Intensity of Pain and Other Physical and Psychological Symptoms in Adolescents and Young Adults Diagnosed with Cancer on Referral to a Palliative Care Service.

Hughes RE, Holland LR, Zanino D, Link E, Michael N, Thompson KE.

J Adolesc Young Adult Oncol. 2015 Jun;4(2):70-5. doi: 10.1089/jayao.2014.0015.

PMID:
26812554

Supplemental Content

Support Center